Download our NEW Mobile App!
6802 Rogers Avenue, Suite 2, Fort Smith, AR 72903 | Phone: (479) 452-6116 | Fax: (479) 484-7409 | Mon-Fri 8:00am - 6:30pm | Sat 9:00am - 2:00pm | Sun Closed

Get Healthy!

Results for search "Cancer: Kidney".

09 May

14 Types of Cancer Are on the Rise in People Under 50, Study Finds

Certain types of cancer are becoming increasingly common in people under 50, according to new research. These include breast, colon, kidney and uterine cancer.

01 Aug

Cancer Rates Rising in Gen Xers and Millennials. The Question Is Why?

Researchers analyzed cancer incidence and mortality rates across generations and found a significant increase in many types of cancer among Generation X and millennials.

Health News Results - 11

Some Cancers Increasing in People Under 50, New Report Shows

FRIDAY, May 9, 2025 (HealthDay News) — More young adults in the U.S. are being diagnosed with cancer, and researchers are trying to figure out why.

A new government report shows that rates of several types of cancer are going up in people under age 50, especially among women...

Epstein-Barr Virus Might Help Trigger Cancer After Kidney Transplant

Key Takeaways

  • Kidney transplant recipients who’ve never been exposed to the Epstein-Barr virus but receive organs from a donor who has been may develop a rare and aggressive cancer

  • As many as 1,200 patients a year could be at risk for that cancer, called post-transplant lymphoproliferative disorder (PTLD)

  • This risk may be much...

Therapeutic Vaccine May Fight Advanced Kidney Cancer

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, researchers report.

The "personalized cancer vaccines" (PCVs) used by the nine patients in the trial were targeted to genes specific to their tumors, explained a team led by Dr. David Braun of the Yale Cancer ...

Combo Treatment Doubles Survival for Patients With Advanced Kidney Cancer

A small clinical trial suggests that a duo of drugs can extend survival for people battling advanced kidney cancer.

Researchers at Roswell Park Comprehensive Cancer Center in Buffalo, N.Y., developed the new regimen, a combination of pazopanib (Votrient) and bevacizumab (Avastin).

<...